Tower Research Capital (TRC)’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27K | Buy |
|
|||||
|
2025
Q1 | $46 | Sell |
|
|||||
|
2024
Q4 | $3.19K | Sell |
|
|||||
|
2024
Q3 | $5.63K | Sell |
|
|||||
|
2024
Q2 | $7.42K | Buy |
|
|||||
|
2024
Q1 | $6.52K | Sell |
|
|||||
|
2023
Q4 | $10.5K | Buy |
|
|||||
|
2023
Q3 | $9.41K | Buy |
|
|||||
|
2023
Q2 | $12.1K | Sell |
|
|||||
|
2023
Q1 | $7K | Buy |
|
|||||
|
2022
Q4 | $7K | Sell |
|
|||||
|
2022
Q3 | $10K | Buy |
|
|||||
|
2022
Q2 | $12K | Buy |
|
|||||
|
2022
Q1 | $7K | Buy |
|
|||||
|
2021
Q4 | $12K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1K | Buy |
|